Manchester manufacturer Lydall Inc. said it has completed the sale of Charter Medical, which makes medical products used in blood transfusions and bioprocessing.
Solesis Medical Technologies — a subsidiary of United Kingdom-based Fenner PLC — bought Charter Medical for $29.9 million, according to Lydall, which said the divestiture will help it focus on its core businesses making thermal, acoustical, filtration and other engineered products.
Charter is based in North Carolina. Lydall formed the company in 1998.
Boston-based C.W. Downer & Co. advised Lydall on the transaction.
